carvedilol has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol (CAR) is a third-generation β-adrenergic receptor antagonist with an α1-blocking effect." | 1.91 | Repurposing of carvedilol to alleviate bleomycin-induced lung fibrosis in rats: Repressing of TGF-β1/α-SMA/Smad2/3 and STAT3 gene expressions. ( Abbas, NAT; Abdelmageed, AF; Afifi, R; Hassan, HA; Mohammed, HO; Nafea, OE; Samy, W, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, NAT | 1 |
| Nafea, OE | 1 |
| Mohammed, HO | 1 |
| Samy, W | 1 |
| Abdelmageed, AF | 1 |
| Afifi, R | 1 |
| Hassan, HA | 1 |
1 other study available for carvedilol and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Repurposing of carvedilol to alleviate bleomycin-induced lung fibrosis in rats: Repressing of TGF-β1/α-SMA/Smad2/3 and STAT3 gene expressions.
Topics: Actins; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Bleomycin; Carve | 2023 |